AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Melanoma Stage III

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma NCT03860883NA192 sites๐Ÿ“ Mobile๐Ÿ“ Gilbert๐Ÿ“ Phoenix Melanoma and Skin Cancer Trials Limited ยท Tests: Wide Local Excision = 1cm Margin, Wide Local Excision = 2cm Margin Versatile Ampification Single-Molecule Detection in Liquid Biopsy NCT05940311n/a1 site๐Ÿ“ Rome Regina Elena Cancer Institute ยท Tests: Blood sampling in addition to the blood normally required for their clinical management, Blood plasma and circulating tโ€ฆ Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma NCT04598009Phase 22 sites๐Ÿ“ La Jolla๐Ÿ“ San Francisco University of California, San Francisco ยท Tests: Binimetinib, Imatinib Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivoยฎ as Adjuvant Monotherapy in Participants With Melanoma NCT07476326Phase 146 sites๐Ÿ“ Bento Gonรงalves๐Ÿ“ Ijuรญ๐Ÿ“ Parรก Biocon Biologics UK PLC ยท Tests: Bmab1700, Opdivo A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors NCT05970497Phase 1, Phase 215 sites๐Ÿ“ Los Angeles๐Ÿ“ Rancho Santa Margarita๐Ÿ“ Weston Krystal Biotech, Inc. ยท Tests: KB707, Opdualag, KEYTRUDA ยฎ( Pembrolizumab) A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma NCT06624644Phase 2, Phase 39 sites๐Ÿ“ Newport Beach๐Ÿ“ San Francisco๐Ÿ“ Stanford Linnaeus Therapeutics, Inc. ยท Tests: LNS8801, Pembrolizumab, Chemotherapy (dacarbazine or temozolomide), Immunotherapy (Pembrolizumab), Immunotherapy (nivolโ€ฆ Neoadjuvant Combination Immunotherapy for Stage III Melanoma NCT03842943Phase 21 site๐Ÿ“ Louisville University of Louisville ยท Tests: Pembrolizumab, Talimogene Laherparepvec Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies NCT06508775NA7 sites๐Ÿ“ Berlin๐Ÿ“ Cologne๐Ÿ“ Erlangen Miltenyi Biomedicine GmbH ยท Tests: MB-CART19.1, MB-CART20.1, MB-CART2019.1 Neoadjuvant and Adjuvant Anti-PD1 or Combinations for Locoregionally Advanced Melanoma NCT06295159Phase 21 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Nivolumab, Nivolumab + Relatlimab, Ipilimumab Immunotherapy or Targeted Therapy With or Without Stereotactic Radiosurgery for Patients With Brain Metastases From Melanoma or Non-small Cell Lung Cancer NCT05522660Phase 315 sites๐Ÿ“ Naples๐Ÿ“ Padova๐Ÿ“ Perugia ETOP IBCSG Partners Foundation ยท Tests: Stereotactic radiosurgery, Immune checkpoint inhibitor Adjuvant Melatonin for Uveal Melanoma NCT05502900Phase 31 site๐Ÿ“ Stockholm Gustav Stalhammar ยท Tests: Melatonin Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) Program NCT06265285Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Home Health Encounter, Nivolumab, Patient Monitoring, Questionnaire Administration Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy Predictive Clinical Features for Response to Adjuvant Immunotherapy in Stage II,III and IV Resected Melanoma NCT05527795n/a1 site๐Ÿ“ Pierre-Bรฉnite Hospices Civils de Lyon ยท Tests: Frequency and duration of response to adjuvant immunotherapy according to clinical features, Frequency of each type of โ€ฆ Adjuvant Tebentafusp in High Risk Ocular Melanoma NCT06246149Phase 315 sites๐Ÿ“ Lake Success๐Ÿ“ Brussels๐Ÿ“ Nice European Organisation for Research and Treatment of Cancer โ€ฆ ยท Tests: Tebentafusp To Evaluate the Safety and Efficacy of ADP-TILIL7 in Patients With Locally Advanced or Metastatic Melanoma NCT06204991Phase 12 sites๐Ÿ“ Herlev๐Ÿ“ Herlev Inge Marie Svane ยท Tests: ADP-TILIL7, Cyclophosphamide, Fludarabine Phosphate, Proleukin Efficacy and Safety of Neoadjuvant Cadonilimab Plus High-Dose Recombinant Human Interferon ฮฑ1b in Stage III/IV Melanoma. NCT07586904EARLY Phase 11 site๐Ÿ“ Xi'an Xijing Hospital ยท Tests: Cadonilimab and Recombinant Human Interferon ฮฑ1b Combination Therapy Omitting Therapeutic Lymph Node Dissection in Patients With Melanoma (Stage 3) and Major Pathological Response in the Index Lymph Node NCT06754904NA1 site๐Ÿ“ Rotterdam D.J. (Dirk) Grรผnhagen ยท Tests: Omitting TLND, Index node procedure Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors NCT04119024Phase 13 sites๐Ÿ“ Duarte๐Ÿ“ Los Angeles๐Ÿ“ Stanford Anusha Kalbasi ยท Tests: Biopsy, Biospecimen Collection, Computed Tomography, Cyclophosphamide, Fludarabine Phosphate Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment NCT04045691n/a59 sites๐Ÿ“ Graz๐Ÿ“ Innsbruck๐Ÿ“ Klagenfurt Pierre Fabre Pharma GmbH ยท Tests: Encorafenib, Binimetinib Duration of Anti-PD-1 Therapy in Metastatic Melanoma NCT02821013Phase 330 sites๐Ÿ“ Victoria๐Ÿ“ Coffs Harbour๐Ÿ“ Waratah Canadian Cancer Trials Group ยท Tests: Intermittent PD-1 inhibitor therapy, Continuous PD-1 inhibitor therapy Interleukin-6 Receptor Inhibitor Sarilumab in Combination With Ipilimumab, Nivolumab and Relatlimab in Patients With Unresectable Stage III or Stage IV Melanoma NCT05428007Phase 24 sites๐Ÿ“ Los Angeles๐Ÿ“ Boston๐Ÿ“ Boston NYU Langone Health ยท Tests: Sarilumab, Ipilimumab Injection, Nivolumab/Relatlimab A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head) NCT06246916Phase 3113 sites๐Ÿ“ Chandler๐Ÿ“ Gilbert๐Ÿ“ Tucson Regeneron Pharmaceuticals ยท Tests: fianlimab, cemiplimab, relatlimab+nivolumab Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma NCT06488482Phase 326 sites๐Ÿ“ Helsinki๐Ÿ“ Kuopio๐Ÿ“ Tampere Uppsala University ยท Tests: nivolumab or pembrolizumab A Study to Investigate the Efficacy and Safety of an Infusion of IOV-4001 in Adult Participants With Unresectable or Metastatic Melanoma or Stage III or IV Non-small-cell Lung Cancer NCT05361174Phase 1, Phase 211 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Orlando Iovance Biotherapeutics, Inc. ยท Tests: IOV-4001 Predictive Factors of Complete Response to Immunotherapy in Metastatic Melanoma: a Single-center Retrospective Study Between 2013 and 2021 NCT07302607n/a1 site๐Ÿ“ Strasbourg University Hospital, Strasbourg, France MC1R-targeted Alpha-particle Monotherapy and Combination Therapy Trial With Nivolumab in Adults With Advanced Melanoma NCT05655312Phase 1, Phase 216 sites๐Ÿ“ Orange๐Ÿ“ Jacksonville๐Ÿ“ Miami Perspective Therapeutics ยท Tests: [203Pb]VMT01, [212Pb]VMT01, Nivolumab A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors NCT04913285Phase 148 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ San Diego Pierre Fabre Medicament ยท Tests: KIN-2787, KIN-2787 and binimetinib FMT to Convert Response to Immunotherapy NCT05251389Phase 1, Phase 21 site๐Ÿ“ Amsterdam The Netherlands Cancer Institute ยท Tests: Fecal microbiota transplantation Neoadjuvant SHR-1210 Plus Apatinib for Resectable Stage III-IV Acral Melanoma NCT04331093Phase 21 site๐Ÿ“ Changchun Di Wu ยท Tests: SHR-1210+Apatinib
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy